scholarly article | Q13442814 |
P2093 | author name string | Just H | |
Drexler H | |||
Zeiher AM | |||
Saurbier B | |||
P2860 | cites work | Vascular endothelial cells synthesize nitric oxide from L-arginine | Q28291036 |
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes | Q34180296 | ||
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator | Q34209959 | ||
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans | Q34256239 | ||
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta | Q34555162 | ||
Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment | Q34565968 | ||
Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit | Q35589433 | ||
Endothelium-dependent hyperpolarization of canine coronary smooth muscle | Q35755374 | ||
Glucosylation of human collagen in aging and diabetes mellitus | Q37025137 | ||
Regulatory functions of the vascular endothelium | Q37816182 | ||
Understanding the coronary circulation through studies at the microvascular level | Q37818166 | ||
Modulation of vascular smooth muscle contraction by the endothelium | Q39441004 | ||
Endothelial modulation of coronary tone | Q39632210 | ||
Large conduit arteries in hypertension: role of the vascular renin-angiotensin system | Q39636936 | ||
The pathogenesis of atherosclerosis--an update | Q39726917 | ||
L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits | Q40340324 | ||
Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin | Q41143397 | ||
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease | Q41193242 | ||
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. | Q41224359 | ||
Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates | Q41380111 | ||
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries | Q41381379 | ||
Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP | Q41555372 | ||
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol | Q41822574 | ||
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension | Q43789338 | ||
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries | Q44139534 | ||
Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis | Q44480536 | ||
Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries | Q44781738 | ||
Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium | Q46361119 | ||
Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis | Q46418278 | ||
Effects of short-term, diet-induced hypercholesterolemia on systemic hemodynamics, myocardial blood flow, and infarct size in awake dogs with acute myocardial infarction | Q47427639 | ||
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease | Q48508912 | ||
Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. | Q50874741 | ||
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. | Q50879052 | ||
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. | Q50909381 | ||
Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. | Q53880802 | ||
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. | Q54310603 | ||
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. | Q54322623 | ||
Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. | Q54325726 | ||
Characteristics of canine coronary resistance arteries: importance of endothelium. | Q54346833 | ||
Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. | Q54357875 | ||
Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin. | Q54408452 | ||
Coronary hemodynamic determinants of epicardial artery vasomotor responses during sympathetic stimulation in humans | Q68061485 | ||
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis | Q68189712 | ||
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients | Q68195411 | ||
Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina | Q68195415 | ||
Reactivity of isolated porcine coronary resistance arteries to cholinergic and adrenergic drugs and transmural pressure changes | Q68286203 | ||
Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine | Q68326802 | ||
Differential alteration of vascular reactivity in rabbit aorta with modest elevation of serum cholesterol | Q68914237 | ||
A quantitative analysis of blood-brain barrier ultrastructure in the aging human | Q69032907 | ||
Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits | Q69054705 | ||
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man | Q69375610 | ||
Microvascular distribution of coronary vascular resistance in beating left ventricle | Q69633975 | ||
Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction | Q69688186 | ||
Flow-dependent coronary artery dilatation in humans | Q69695223 | ||
Flow effects on prostacyclin production by cultured human endothelial cells | Q69884870 | ||
Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110 | Q69988639 | ||
Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease | Q70143607 | ||
Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide | Q70168117 | ||
The microcirculation in coronary ischemia. Are native anticoagulant mechanisms a path to new therapies? | Q70212280 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
hypercholesterolemia | Q762713 | ||
atherosclerosis | Q12252367 | ||
hypertension | Q95566669 | ||
P304 | page(s) | 652-662 | |
P577 | publication date | 1993-08-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension | |
P478 | volume | 92 |
Q44673741 | ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles |
Q35089883 | AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats |
Q71606965 | Abnormal coronary vasomotion in hypertension: role of coronary artery disease |
Q50133226 | Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence. |
Q47603822 | Aerobic exercise training-induced changes in serum C1q/TNF-related protein levels are associated with reduced arterial stiffness in middle-aged and older adults |
Q28390251 | Aging and vascular endothelial function in humans |
Q34961842 | Aging, ion channel expression, and vascular function |
Q71879928 | Aging-associated endothelial dysfunction in humans is reversed by L-arginine |
Q35829890 | Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders |
Q73304618 | Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries |
Q34013090 | Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies |
Q41292942 | Alterations of coronary blood flow and myocardial perfusion in hypercholesterolaemia |
Q40952734 | Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial |
Q28188525 | Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes |
Q35696305 | Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases |
Q36801342 | Antihyperlipidemic effects of Citrus sinensis, Citrus paradisi, and their combinations |
Q35907558 | Are cardiovascular disease and osteoporosis directly linked? |
Q38542436 | Arterial structure and function in vascular ageing: are you as old as your arteries? |
Q54054337 | Assessment of endothelium-mediated vasodilation of the peripheral circulation by transcutaneous ultrasonography and venous occlusion plethysmography. |
Q33744856 | Association of lifestyle-related factors with circadian onset patterns of acute myocardial infarction: a prospective observational study in Japan. |
Q43529199 | Associations between reactive oxygen species, blood pressure and arterial stiffness in black South Africans: the SABPA study. |
Q37100474 | Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension |
Q39678828 | Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence |
Q34990177 | Atherosclerosis and cancer: common pathways on the vascular endothelium. |
Q73782365 | Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy |
Q34122524 | Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol |
Q35597501 | Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury. |
Q28377505 | Calf and forearm blood flow in hypercholesterolemic patients |
Q41588632 | Candidate genes, small effects, and the prediction of atherosclerosis |
Q41266826 | Cardiovascular effects of exercise: role of endothelial shear stress |
Q36792050 | Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women |
Q36098906 | Cell senescence reduced the mechanotransduction sensitivity of porcine angular aqueous plexus cells to elevation of pressure |
Q32062993 | Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins |
Q48113987 | Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries |
Q50948818 | Chinese adults are less susceptible than whites to age-related endothelial dysfunction. |
Q73356304 | Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels |
Q54061352 | Chronic increases in transmural pressure reduce NO-mediated dilations in isolated resistance arteries of the hamster. |
Q71751796 | Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease |
Q50852106 | Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. |
Q40834666 | Clinical implications of endothelial dysfunction. |
Q93127348 | Coffee and Endothelial Function: A Coffee Paradox? |
Q43768415 | Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients |
Q44404840 | Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia |
Q49486095 | Contractile Responses in Spontaneously Hypertensive Rats after Transient Middle Cerebral Artery Occlusion. |
Q40403384 | Control of coronary blood flow by autacoids |
Q35029180 | Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients |
Q47389819 | Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy |
Q43930831 | Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy |
Q34419008 | Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis |
Q41349612 | Coronary endothelial function in health and disease. |
Q44120526 | Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease |
Q33802871 | Coronary microembolization--its role in acute coronary syndromes and interventions |
Q33967744 | Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. |
Q31758593 | Coronary spastic angina induced by anticholinesterase medication for myasthenia gravis--a case report |
Q40397425 | Coronary vasomotor responses: role of endothelium and nitrovasodilators |
Q41672794 | Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease |
Q71724517 | Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers |
Q77993591 | Determinants of retinopathy progression in type 1 diabetes mellitus |
Q37277653 | Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction. |
Q94278450 | Dietary Fats and Coronary Heart Disease |
Q73407541 | Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics |
Q62661500 | Does Lipoprotein(a) Impair Endothelial Function? |
Q77718606 | Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis |
Q44124400 | Effect of ACE inhibitors on endothelial dysfunction: unanswered questions and implications for further investigation and therapy |
Q44210558 | Effect of HMG-CoA reductase inhibition on endothelial dysfunction-inducing protein in hypercholesterolemic rabbits |
Q73832085 | Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation |
Q37358590 | Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery |
Q43988603 | Effect of endurance training on coronary artery size and function in healthy men: an invasive followup study |
Q44632176 | Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients |
Q79147894 | Effects of Quyu Xiaoban Capsule on vascular endothelial function in patients with atherosclerosis |
Q74348251 | Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients |
Q37033552 | Effects of exercise training and hypercholesterolemia on adenosine activation of voltage-dependent K+ channels in coronary arterioles |
Q73995256 | Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction |
Q71656149 | Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia |
Q42524781 | Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats |
Q37222753 | Endothelial and non-endothelial coronary blood flow reserve and left ventricular dysfunction in systemic hypertension. |
Q35118818 | Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes |
Q46431030 | Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors |
Q38042870 | Endothelial dysfunction and hypertension in aging |
Q43894412 | Endothelial dysfunction in cold-induced hypertensive rats |
Q28195411 | Endothelial dysfunction: a comprehensive appraisal |
Q36874825 | Endothelial dysfunction: does it matter? Is it reversible? |
Q40861583 | Endothelial dysfunction: implications for therapy of cardiovascular diseases |
Q41274640 | Endothelial function in different organs |
Q43244784 | Endothelial function in subjects with isolated low HDL cholesterol: role of nitric oxide and circulating progenitor cells |
Q36936335 | Endothelial function, arterial stiffness and lipid lowering drugs |
Q40311493 | Endothelial progenitor cells: from bench to bedside |
Q28584822 | Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice |
Q41671991 | Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans |
Q37639902 | Endothelium and its alterations in cardiovascular diseases: life style intervention |
Q36442609 | Endothelium, aging, and hypertension |
Q24650963 | Endothelium-dependent contractions and endothelial dysfunction in human hypertension |
Q35048636 | Endothelium-dependent contractions in hypertension |
Q50477086 | Endothelium-dependent induction of vasorelaxation by the butanol extract of Phellinus igniarius in isolated rat aorta. |
Q44586114 | Enhanced endothelial nitric oxide-synthase activity in mice infected with Trypanosoma brucei |
Q51558504 | Enhanced endothelium-dependent vasodilation in older endurance-trained men. |
Q50127484 | Essential Hypertension and Functional Microvascular Ageing. |
Q34398574 | Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle |
Q33257976 | Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy |
Q44416309 | Exercise training improves ageing‐induced decrease in eNOS expression of the aorta |
Q34648131 | Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial |
Q46416854 | Fibrinogen/LDL apheresis for treatment of sudden hearing loss: an observational study on 152 patients |
Q55035577 | Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects. |
Q47788358 | Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. |
Q74172116 | Heterogeneous vasomotor responses of coronary conduit and resistance vessels in hypertension |
Q37682645 | Human endothelial dysfunction: EDCFs. |
Q47976989 | Impact of combined hormonal contraceptives on vessels functionality. |
Q73164939 | Impaired endothelial function in patients with rapidly stabilized unstable angina: assessment by noninvasive brachial artery ultrasonography |
Q41715228 | Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease |
Q39776974 | Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats |
Q47702903 | Improvement of coronary vasodilatation capacity through single LDL apheresis |
Q30922580 | Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension |
Q73119586 | Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients |
Q52014753 | Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease |
Q36294143 | Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients |
Q36617640 | In utero exposure to benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life. |
Q77654153 | Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period |
Q45285440 | Increased tolerance to hypoxic metabolic inhibition and reoxygenation of cardiomyocytes from apolipoprotein E-deficient mice |
Q37879391 | Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae |
Q43735009 | Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats |
Q41653555 | Is there a menopausal metabolic syndrome? |
Q33928332 | Ischemia and fibrosis: the risk mechanisms of hypertensive heart disease |
Q42074572 | L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition |
Q35951214 | Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study |
Q34550915 | Lipids and endothelium-dependent vasodilation--a review |
Q73746087 | Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation |
Q73132681 | Long-term estrogen therapy abolishes acute estrogen-induced coronary flow augmentation in postmenopausal women |
Q82604969 | Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers |
Q39437777 | Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). |
Q72883708 | Low dose calcium-antagonism compensates for impaired myocardial blood supply resulting from deficient nitric oxide synthesis |
Q34809311 | Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us? |
Q37276523 | Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases |
Q36769566 | Mechanisms by which low-intensity ultrasound improve tolerance to ischemia-reperfusion injury |
Q35989396 | Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. |
Q53827857 | Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. |
Q34180939 | Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors |
Q42522933 | Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. |
Q38605600 | Nitric oxide and cardiovascular risk factors. |
Q71111843 | Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients |
Q73975793 | Nuclear imaging and endothelial dysfunction |
Q37773166 | Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. |
Q35549761 | Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions |
Q37078045 | Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease |
Q71827242 | Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events |
Q43559008 | Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism |
Q43190381 | Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase |
Q90410833 | Quantitative and Dynamic MRI Measures of Peripheral Vascular Function |
Q99581945 | Rare Case of Iatrogenic Myocardial Infarction Induced by Use of Pyridostigmine |
Q77082349 | Reactive hyperemic response of the brachial artery: comparison of proximal and distal occlusion |
Q34387386 | Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. |
Q46752953 | Reduced brachial flow-mediated vasodilation in young adult ex extremely low birth weight preterm: a condition predictive of increased cardiovascular risk? |
Q35581117 | Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation |
Q41718494 | Regulation of myocardial blood flow response to mental stress in healthy individuals |
Q51560581 | Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. |
Q57315653 | Relation of inflammation to vascular function in patients with coronary heart disease |
Q73470369 | Relation of pacing-induced coronary resistance vessel dilation to total serum cholesterol and heart rate-blood pressure product |
Q77361803 | Reliability of fractional flow reserve measurements in patients with associated microvascular dysfunction: importance of flow on translesional pressure gradient |
Q36818981 | Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase |
Q72057673 | Report of the NHLBI Working Group on research in coronary heart disease in blacks: issues and challenges |
Q39092000 | Review: Promise of prevention and reversal of target organ involvement in hypertension |
Q37151565 | Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease |
Q36017117 | Role of PET in the evaluation and understanding of coronary physiology. |
Q44462044 | Serum lipid/lipoprotein and arterial blood pressure among Chinese nonagenarians/centenarians |
Q46463411 | Serum uric acid and slow coronary flow in cardiac syndrome X. |
Q44761374 | Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia |
Q47685461 | Short-term therapy with relatively low-dose cerivastatin improves endothelial function independently of its lipid-lowering effect: Evaluation of brachial artery vasodilatation using B-mode ultrasound imaging |
Q73009124 | Simvastatin increases plasma NO2- and NO3- levels in patients with hypercholesterolemia |
Q31041112 | Skin vessel reactivity tests in healthy middle-aged and elderly subjects: the influence of depolarizating current and serum lipids |
Q44551854 | Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin |
Q28196669 | Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? |
Q35660829 | Target organ involvement in hypertension: a realistic promise of prevention and reversal |
Q35751537 | Tegaserod-induced myocardial infarction: case report and hypothesis |
Q45146736 | Tegaserod-induced myocardial infarction: case report and hypothesis--an alternative viewpoint |
Q30813656 | Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia |
Q45004497 | Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia |
Q43610482 | Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? |
Q48377363 | The 1998 Nobel prize in Medicine: clinical implications for 1999 and beyond |
Q35046516 | The L-arginine-nitric oxide pathway in hypertension |
Q34075142 | The association of infection and coronary artery disease: an update |
Q36464649 | The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease. |
Q28363031 | The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis |
Q35055194 | The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function |
Q39556429 | The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone |
Q39801577 | The prevalence of endothelial dysfunction in patients with and without coronary artery disease. |
Q33989516 | The research on endothelial function in women and men at risk for cardiovascular disease (REWARD) study: methodology |
Q35553615 | The volatile oil of Nardostachyos Radix et Rhizoma induces endothelial nitric oxide synthase activity in HUVEC cells |
Q92108305 | Therapeutic Angiogenesis with Somatic Stem Cell Transplantation |
Q31886177 | Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases |
Q28344870 | Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice |
Q46443065 | Transition in the mechanism of flow-mediated dilation with aging and development of coronary artery disease. |
Q52079534 | Transvascular albumin leakage and forearm vasodilatation to acetylcholine in essential hypertension. |
Q31855511 | Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action |
Q77098045 | Vascular disease and lipids in diabetes |
Q38418718 | Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease |
Q37335759 | Vascular endothelial senescence: from mechanisms to pathophysiology. |
Q33957964 | Vascular oxidant stress: molecular mechanisms and pathophysiological implications |
Q77958150 | Vasomotor responses of coronary stenoses to acetylcholine and their relation to serum lipid levels in stable angina pectoris |
Q80287074 | WITHDRAWN: [Effects of atorvastatin on presbyacusis and tinnitus : A prospective, randomized, double-blind clinical trial.] |
Q50859542 | Wall shear stress in the human common carotid artery as function of age and gender. |
Q38108378 | What is the mechanism of flow-mediated arterial dilatation |
Q54138038 | [Analysis of forearm circulation--a substitute for diagnosis of coronary atherosclerosis?]. |
Q73047267 | [Cardiovascular syndrome X and endothelial dysfunction] |
Q74564760 | [Methods for coronary functional assessment] |
Q74564766 | [The role of endothelial function for ischemic manifestations of coronary atherosclerosis] |
Search more.